Ani Pharmaceuticals (ANIP) FCF Payout Ratio Growth (1y) (2022 - 2025)
Ani Pharmaceuticals (ANIP) FCF Payout Ratio Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 15.81% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -130.26% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 37.82% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -99.44% |
| Jun 30, 2025 | -75.81% |
| Mar 31, 2025 | -49.82% |
| Dec 31, 2024 | 53.08% |
| Sep 30, 2024 | 14,608.80% |
| Jun 30, 2024 | 6.50% |
| Mar 31, 2024 | 11.90% |
| Dec 31, 2023 | 110.38% |
| Sep 30, 2023 | -88.58% |
| Jun 30, 2023 | 166.26% |
| Mar 31, 2023 | 200.88% |
| Dec 31, 2022 | -467.28% |